Effects of atorvastatin and rosuvastatin on renal function in patients at high cardiovascular risk: a meta-analysis of 21 randomized trials

被引：0
|
作者：
Savarese, G. [1 ]
Volpe, M. [2 ]
Musella, F. [1 ]
Casaretti, L. [1 ]
Perrone-Filardi, P. [1 ]
机构：
[1] Univ Naples Federico II, Dpt Clin Med Cardiovasc & Immunol Sci, Naples, Italy
[2] Univ Roma La Sapienza, Dept Clin & Mol Med, Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：950 / 950
页数：1
相关论文
共 50 条
  • [31] Effects of renin–angiotensin system blockers on renal and cardiovascular outcomes in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials
    X. Liu
    L. Ma
    Z. Li
    Journal of Endocrinological Investigation, 2020, 43 : 959 - 972
  • [32] Pioglitazone and cardiovascular risk. A comprehensive meta-analysis of randomized clinical trials
    Mannucci, E.
    Monami, M.
    Lamanna, C.
    Gensini, G. F.
    Marchionni, N.
    DIABETES OBESITY & METABOLISM, 2008, 10 (12): : 1221 - 1238
  • [33] Apolipoprotein B and risk of cardiovascular disease: A meta-analysis of randomized controlled trials
    Galimberti, Federica
    Catapano, Alberico L.
    Katzmann, Julius L.
    Cupido, Arjen J.
    Ference, Brian A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 53 - 53
  • [34] Effects of Berries Consumption on Cardiovascular Risk Factors: A Meta-analysis with Trial Sequential Analysis of Randomized Controlled Trials
    Huang, Haohai
    Chen, Guangzhao
    Liao, Dan
    Zhu, Yongkun
    Xue, Xiaoyan
    SCIENTIFIC REPORTS, 2016, 6
  • [35] Effects of Berries Consumption on Cardiovascular Risk Factors: A Meta-analysis with Trial Sequential Analysis of Randomized Controlled Trials
    Haohai Huang
    Guangzhao Chen
    Dan Liao
    Yongkun Zhu
    Xiaoyan Xue
    Scientific Reports, 6
  • [36] Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials
    Lincoff, A. Michael
    Wolski, Kathy
    Nicholls, Stephen J.
    Nissen, Steven E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (10): : 1180 - 1188
  • [37] SGLT2 Inhibitors in Diabetic Patients With Cardiovascular Disease or at High Cardiovascular Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Zhao, Zinan
    Jin, Pengfei
    Zhang, Yatong
    Hu, Xin
    Tian, Chao
    Liu, Deping
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [38] Effects of HDL-modifiers on cardiovascular outcomes: A meta-analysis of randomized trials
    Verdoia, M.
    Schaffer, A.
    Suryapranata, H.
    De Luca, G.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2015, 25 (01) : 9 - 23
  • [39] Effects Of Semaglutide On Safety Outcomes In Patients With Type 2 Diabetes Mellitus And High Cardiovascular Risk: A Meta-Analysis Of Randomized Controlled Trials And Systematic Review
    Akabane, Maria Antonia Cruz
    Mazetto, Roberto
    Ribeiro, Iury
    Cavalcante, Douglas
    Barbosa, Imara
    CIRCULATION, 2024, 150
  • [40] COST-EFFECTIVENESS ANALYSIS OF ROSUVASTATIN COMPARED TO ATORVASTATIN IN SPANISH PATIENTS AT MODERATE, HIGH, AND VERY HIGH CARDIOVASCULAR RISK
    Garcia-Goni, M.
    Facila, L.
    Cinza, S.
    Pinto, X.
    Cortes, X.
    Prades, M.
    Aceituno, S.
    VALUE IN HEALTH, 2018, 21 : S104 - S105
12345